New diabetes clinical trial: A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

Published on: July 10, 2025 at 11:00PM
Conditions: Type 1 Diabetes; New Onset
Interventions: Drug: Anti-thymocyte globulin (ATG); Drug: verapamil extended-release capsule; Drug: Adalimumab
Sponsors: City of Hope Medical Center; Jaeb Center for Health Research
Not yet recruiting
https://ift.tt/UzvDETo